Evidence mapPaperPMID 41438191Full record

Trial reportFrontiers in nutrition2025

A standardized combination of

Dawna Salter, Silla Vijaya Bhaskara Gupta, Bendi Sairam, Ashish Kumar Gupta, Ravishankar Maurya

Abstract readClinical Trial
In one paragraph

Trial report in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dawna SalterClinical Research and Innovation Division, PLT Health Solutions, Morristown, NJ, United States.
Silla Vijaya Bhaskara GuptaDepartment of Psychiatry, Government Medical College and General Hospital, Andhra Pradesh, India.
Bendi SairamDepartment of Psychiatry, Government Medical College and General Hospital, Andhra Pradesh, India.
Ashish Kumar GuptaPsychiatry Division, Arogya Jana Seva Kendra, Uttar Pradesh, India.
Ravishankar MauryaPsychiatry Division, Arogya Jana Seva Kendra, Uttar Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Methods: One hundred participants aged 40-65 with subjective complaints of poor memory were randomized into two groups: 300 mg of LN19184 or placebo, once daily for 120 days. At baseline and days 15, 30, 60, and 120, two neuropsychological batteries, the Rey's Auditory Verbal Learning Test (RAVLT) and the Cambridge Neuropsychological Test (CANTAB), were used to assess cognitive function, and the Athens Insomnia Scale was used to evaluate sleep quality. Serum BDNF levels and safety parameters were also assessed. Results: LN19184 improved each measured RAVLT outcome compared to placebo. Supplementation improved proactive interference ( Conclusion: This pilot trial provides early empirical evidence demonstrating that a novel extract blend of Clinical trial registration: Clinicaltrials.gov, identifier CTRI/2020/08/027368.

Indexed as

amyrinAthens insomnia scaleboswellic acidsbrain-derived neurotrophic factorcognitive functiondietary supplementRey’s auditory verbal learning testsleep quality

Identifiers

PMID41438191
PMCPMC12719083

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.